By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3.5% on Monday after ...

Patients with obesity have lost up to 15pc of their body weight in trials of a new drug that far outperforms competitors such ...

Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...

Results from the Phase III REDEFINE 1 trial show that CagriSema led to a 22.7% mean weight reduction at 68 weeks in adults ...

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...

Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, ...

Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg ...

Projections show half of ten and 11-year-olds could be overweight or obese in some areas, with experts calling for urgent ...

Obesity caused by a high-fat Western diet damages the pancreas, affecting insulin production and blood sugar control even ...

A new report reveals a stark rise in childhood obesity rates across England, with projections showing that more than 40% of ...

The term sheet was signed in the presence of senior officials from BIRAC, the department of biotechnology, and industry ...

On June 19, 2025 The Globe and Mail hosted an event where experts discussed how treating obesity as a chronic disease can ...